Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Agilent TechnologiesA -0.25%94 3-1 Month Momentum % is 14.95% as of Aug. 03, 2026. GuruFocus rates A with a GF Score™ of 94/100 and a GF Value™ of $146.44 (Fairly Valued). The stock has 3 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Agilent Technologies ranks better than 75.12% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-03), Agilent Technologies's 3-1 Month Momentum % is 14.95%.
The industry rank for Agilent Technologies's 3-1 Month Momentum % or its related term are showing as below:
A's 3-1 Month Momentum % is ranked better than 75.12% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: -4.42
vs A: 14.95
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Agilent Technologies 3-1 Month Momentum % Related Terms
A vs NTRA, WAT, IDXX: 3-1 Month Momentum % Comparison
For the Diagnostics & Research subindustry, Agilent Technologies's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies 3-1 Month Momentum % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies (A) has a 3-1 Month Momentum % of 14.95% as of Aug. 03, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Agilent Technologies and its competitors. According to the industry distribution chart, Agilent Technologies ranks #53 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 24.9%.
Is Agilent Technologies' 3-1 Month Momentum % too high?
Agilent Technologies' current 3-1 Month Momentum % is 14.95%. Based on the distribution chart, Agilent Technologies ranks #53 out of 213 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Agilent Technologies has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' 3-1 Month Momentum % compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #53 out of 213 companies for 3-1 Month Momentum %. This places Agilent Technologies in the top 25% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Diagnostics & Research company?
A good 3-1 Month Momentum % depends on the Medical Diagnostics & Research industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Agilent Technologies and its competitors. Agilent Technologies's current 3-1 Month Momentum % is 14.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (A) is currently considered Fairly Valued. The stock's GF Value™ is $146.44, compared to a current price of $138.37 — trading 5.5% below its estimated fair value. The current 3-1 Month Momentum % is 14.95%. Agilent Technologies' overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Agilent Technologies (A), the current 3-1 Month Momentum % is 14.95% as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (A) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of $138.37 is trading 5.5% below its estimated GF Value™ of $146.44.
GuruFocus considers Agilent Technologies to be Fairly Valued.
Key valuation signals for A:
3-1 Month Momentum %: 14.95%
GF Value™: $146.44 vs. price of $138.37 (5.5% below fair value)
No single metric tells the full story. See the A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
94GF Score
Get the complete analysis for A
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
A has been successfully added to your 
